The Senate passed a set of government funding bills on Friday that includes provisions designed to rein in intermediaries in the prescription drug supply chain called pharmacy benefit managers. The appropriations package expands reporting obligations for PBMs aimed at increasing transparency in their operations. It also shifts PBM compensation in Medicare’s Part D (outpatient drug […]
